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Epidemiologic evidence suggests that cigarette smoking is a risk
factor for infection with influenza, but the mechanisms underlying
this susceptibility remain unknown. To ascertain if airway epithelial
cells from smokers demonstrate a decreased ability to orchestrate an
influenza-induced immune response, we established a model using
differentiated nasal epithelial cells (NECs) from nonsmokers and
smokers, co-cultured with peripheral blood monocyte–derived den-
dritic cells (mono-DCs) from nonsmokers. NEC/mono-DC co-cultures
were infected with influenza A virus and analyzed for influenza-
induced immune responses 24 hours after infection. We observed
that NECs from smokers, as well as mono-DCs co-cultured with NECs
from smokers, exhibited suppressed influenza-induced, interferon-
related proteins interferon regulatory factor–7, Toll-like receptor–3,
and retinoic acid inducible gene–1, likely because of the suppressed
production of IFNa from the NECs of smokers. Furthermore, NEC/
mono-DC co-cultures using NECs from smokers exhibited sup-
pressed concentrations of T-cell/natural killer cell chemokine in-
terferon gamma–induced protein 10 (IP-10) after infection with
influenza, indicating that NECs from smokers may skew early
influenza-induced Th1 responses. In contrast, NEC/mono-DC co-
cultures using NEC from smokers contained increased influenza-
induced concentrations of the Th2 chemokine thymic stromal
lymphopoeitin (TSLP). In addition, NECs from smokers cultured
alone had increased influenza-induced concentrations of the Th2
chemokine thymus and activation-regulated chemokine (TARC).
Using this model, we demonstrated that in the context of infection
with influenza, NECs obtained from smokers create an overall
cytokine microenvironment that suppresses the interferon-
mediated Th1 response and enhances the TSLP–TARC–mediated
Th2 response, with the potential to modify the responses of DCs.
Smoking-induced alterations in the Th1/Th2 balance may play a role
in developing underlying susceptibilities to respiratory viral infec-
tions, and may also promote the likelihood of acquiring Th2
proallergic diseases.
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Cigarette smoking is a risk factor for infection with respiratory
viruses such as influenza A. After the influenza A epidemic in
Hong Kong of 1968, Finklea and colleagues reported that
smokers who smoked more than 21 cigarettes (z1 pack) per
day were subject to a 21% increase in clinical influenza in-
cidence and an increase in illness severity compared with
nonsmokers (1). Subsequent epidemiologic studies demon-
strated that cigarette smoking leads to an increased incidence
and severity of influenza infection in multiple populations,
including female military recruits (2) from the United States,
male Israeli soldiers (3), and senior citizens in assisted-living
communities (4). A meta-analysis in 2004 confirmed that along
with influenza infections, smokers are increased risk for invasive
pneumococcal disease and tuberculosis (5), and associations
were drawn between smoking and the common cold (6).
Combined with evidence that smokers have lower influenza
vaccination rates than nonsmokers, the increased risk for
infection becomes an even more significant public health issue
(7, 8). However, the mechanisms mediating the enhanced suscep-
tibility to viral infections in smokers are not known. In both
human (9–11) and animal (12) models of influenza, adaptive
humoral immunity, as measured by influenza-specific antibody
production, was unaffected by exposure to cigarette smoke.
Therefore, cigarette smoke more likely affects innate immune
mechanisms during an influenza infection.
Exposure to cigarette smoke was shown to suppress the
innate immune responses of the respiratory epithelium (13).
The influenza virus infects epithelial cells by binding via
hemagglutinin and entering cells via residues of sialic acid,
using endocytosis. Soon after infection, influenza activates the
innate immune system of the respiratory epithelium and
stimulates the generation of cytokines and chemokines (14). Path-
ogen recognition receptors (PRRs), such as Toll-like receptor–3
(TLR-3), and retinoic acid inducible gene–1 protein (RIG-I)
recognize viral RNA and activate nuclear transcription factors
such as NF-kB, interferon regulatory factor–3 (IRF-3), and IFN
regulatory factor–7 (IRF-7) in epithelial cells. The synthesis and
binding of IRFs to interferon response element promoter
regions induce the production of antiviral Type I IFNs (e.g.,
IFNa/b) that help prevent further viral infection. We previously
showed that the expression of IRF-7 is decreased in nasal ep-
ithelial cells (NECs) from smokers after infection with influenza,
yielding a suppressed production of Type I IFN in these cells (13).
Similarly, media conditioned with cigarette smoke were shown to
inhibit the responses of IRF-3, IRF-7, and NF-kB to polyinosi-
nic:polycytidylic acid (poly I:C) in lung epithelial cells and
fibroblasts (15).
The interplay between the airway epithelium and resident
immune cells such as dendritic cells (DCs) is crucial in
mobilizing respiratory immune responses. Activated DCs fulfill
the pivotal task of mobilizing both innate and adaptive immune
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cells by secreting chemokines to attract neutrophils, cytotoxic
and memory T cells, and natural killer (NK) cells (16).
Specifically, DCs produce chemokines such as regulated upon
activation, normal T-cell expressed, and secreted (RANTES)
chemokine (C-X-C motif) ligand 9 (CXCL9), interferon
gamma–induced protein 10 (IP-10), and CXCL11, and drive
a Th1 CD41 T-cell response to expand activated, cytotoxic
pools of T cells (17). The direct infection of DCs with influenza
virus was shown to activate DC antiviral defenses, including
RIG-I, TLR-3, and IRF-7 (18), but whether and how signals
derived from the microenvironment, such as surrounding epi-
thelial cells, modify these effects remains unknown.
Respiratory DCs are capable of responding not only to Th1
cytokines produced during a viral infection, but also to Th2
chemokines produced by a dysregulated respiratory epithelium.
Thymic stromal lymphopoeitin (TSLP) is an epithelial cell–
derived Th2 chemokine that communicates with and induces
Th2 responses in DCs. TSLP acts directly on DCs to increase
the production of thymus and activation-regulated chemokine
(TARC or CCL17) (19), which in turn coaxes naive T cells to
secrete proallergic cytokines such as IL-5, IL-4, IL-13, and
TNFa, which have the potential to foster the development of an
allergic Th2 CD4 T-cell phenotype (20). Although normal
human bronchial epithelial cells were demonstrated to up-
regulate TSLP in response to stimulation with the viral double
stranded RNA (dsRNA) dsRNA mimetic poly-I:C (21), how
the virus-induced expression of TSLP or TARC may be altered
during an influenza infection in smokers is unknown.
In vitro studies that treat DCs directly with cigarette smoke
may not provide the most realistic model system, because
signals derived from the respiratory epithelium are important
in generating the proper microenvironment for the maturation
of DCs in vivo. To address the limitations of human in vitro
airway epithelia models, co-culture systems of airway epithelial
cells and DCs were developed to study the effects of particles
on the airway epithelium (22–24). These models have the
potential to explore the mechanisms of airway epithelial and
immune cell communication during immunologic responses,
including respiratory viral infections. We expanded upon these
models to develop a co-culture system of human NECs obtained
from nonsmokers and smokers and monocyte-derived DCs
(mono-DCs) obtained from healthy nonsmokers, to determine
how smoking-induced changes at the epithelial level affect
communication with resident immune cells.
MATERIALS AND METHODS
Culture of NECs
NECs were obtained from smoking and nonsmoking healthy human
volunteers and differentiated in vitro on 0.4-mM pore size membrane
support, as described previously (13). The criteria for recruiting sub-
jects were similar to those described previously (13, 25). Smoking status
was assessed via questionnaire and confirmed through measurements
of urine cotinine (25). All smokers recruited for the study were current
smokers.
Culture of Mono-DCs, NEC–Mono-DC Co-culture System,
and Infection with Influenza
Peripheral blood monocytes were isolated from healthy nonsmoking
volunteers. Mono-DCs were generated by culturing peripheral blood
monocytes with 30 ng/ml granulocyte/macrophage colony–stimulating
factor (GM-CSF) (Peprotech, Rocky Hill, NJ) and 30 ng/ml IL-4
(Peprotech) for 5–7 days. The differentiation of mono-DCs was con-
firmed using flow cytometry to identify the expression of DC markers
CD86, CD40, CD209, human leukocyte antigen DR (HLA-DR), and
CD11c, as described in the online supplement (BD Biosciences, San
Jose, CA).
Our NEC–mono-DC co-culture system was based on a three-
dimensional cell culture model described previously (22). We applied
1.5 3 105 mono-DCs to the basolateral side of inverted, differentiated
NECs grown on a membrane support of approximately 1.13 cm2 (see
Figure E1 in the online supplement). Mono-DCs were adhered for
2 hours, and then NECs were infected with influenza A/Bangkok/1/79
(H3N2 serotype), as described previously (26). All samples were
collected 24 hours after infection, unless otherwise indicated.
Supernatant Concentrations of Cytokine
The apical surfaces of co-cultured NECs were washed with Hanks’
balanced salt solution. Apical washes and basolateral supernatants
were collected and analyzed for cytokine secretions of IP-10 (BD
Biosciences), RANTES, TARC, and TSLP (all from R&D Systems,
Minneapolis, MN), using commercially available ELISA kits.
Analysis of mRNA from NECs and Mono-DCs
NECs and mono-DCs were removed from the membrane and added
to Trizol (Invitrogen, Carlsbad, CA) for isolation of total RNA. Real-
time, quantitative RT-PCR was performed as described previously (26),
using commercially available primers and probes for TLR-3, RIG-I,
IRF-7, IP-10, and RANTES (Applied Biosystems, Foster City, CA).
Western Blotting
Whole-cell lysates were prepared and analyzed as described elsewhere
(13), using specific antibodies to IRF-7 (Santa Cruz Biotechnology,
Santa Cruz, CA) or b-actin (1:2,000, US Biological, Swampscott, MA).
Visualization of Co-culture System
Co-cultures were fixed with ice-cold methanol for 20 minutes. Anti-
bodies to CD11c (eBioscience, San Diego, CA) and acetylated
a-tubulin (Abcam, Cambridge, MA) were used to identify mono-
DCs and the cilia of NECs, respectively, followed by incubation with
Alexa-488–conjugated and Alexa-596–conjugated secondary anti-
bodies (Invitrogen). Samples were visualized using a Nikon C1Si laser
scanning confocal microscope, and images were processed using EZ-C1
FreeViewer software (Nikon Instruments, Melville, NY).
Statistical Analysis
Data regarding mRNA and mono-DC maturation from co-culture
experiments are expressed as fold induction over noninfected control
samples to determine influenza-induced responses, and were analyzed
using the Wilcoxon signed-rank test. Differences in influenza-induced
and baseline responses between nonsmoker and smoker NECs were
analyzed using a nonparametric Mann-Whitney U test. Protein super-
natant data were analyzed using two-way ANOVA, followed by
Bonferroni post hoc analysis. All data are expressed as mean 6
SEM, with P , 0.05 considered significant.
RESULTS
Development and Visualization of Co-culture Model
To develop mono-DCs, peripheral blood monocytes were in-
cubated with IL-4 and GM-CSF and analyzed for the positive
expression of characteristic DC surface markers. Before co-
culture with NECs, mono-DCs were analyzed by flow cytometry
and shown to demonstrate positive expression of the DC mat-
uration markers CD11b, CD11c, CD86, CD209, and HLA-DR
(data not shown).
To determine whether mono-DCs form networks on the
basolateral side of NECs in our co-culture model, we visualized
the different cell types, using confocal microscopy. Figure 1
(top) provides an en face visualization of the apical border of
the epithelium (left) and the mono-DCs on the basolateral side.
To stain the cilia of NECs, we used mouse anti-acetylated a
tubulin, followed by an Alexa-596–conjugated secondary anti-
body (red), as described previously (26, 27). DCs were identified
using murine anti-CD11c, followed by an Alexa-488–conjugated
secondary antibody (Figure 1, green). Figure 1 (bottom) depicts
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an x–y–z optical cross section of the co-cultureco-culture model,
with the mono-DCs lying basolaterally to the nasal NECs,
a polarization that resembles their in vivo orientation.
Mono-DCs from Nonsmoker and Smoker Co-cultures Have
Similar Levels of DC Maturation after Infection with Influenza
To determine whether surface markers indicating the matura-
tion of DCs are changed in mono-DCs cultured with NECs from
smokers and nonsmokers, we analyzed the surface marker
expression of mono-DCs by flow cytometry after infection with
influenza. Cells were gated (P1) for the positive expression of
leukocyte marker CD45 (Figure 2A). Mono-DCs co-cultureco-
cultured with NECs exhibited a positive baseline expression of
CD11b, CD40, CD209, CD11c, and CD86 (representative histo-
grams in Figures 2B–2F). Figures 2G–2I show that infection
with influenza did not change the expression of CD11b, CD40,
and CD209 in mono-DCs cultured with NECs from either
smokers or nonsmokers. In contrast, the expression of CD11c
was only up-regulated after infection with influenza in mono-
DCs derived from co-cultureco-cultures using NECs from non-
Figure 1. Visualization of the nasal epithelial cell (NEC)/
mono-dendritic cell (DC) co-culture model. Co-culture
membranes were fixed in ice-cold methanol for 20
minutes and stored in 70% ethanol until analysis. Anti-
bodies to CD11c and acetylated a-tubulin were used to
identify mono-DCs and cilia of NECs, respectively. After
incubation with secondary Alexa-596 (NECs, red ) and
Alexa-488 (mono-DCs, green), conjugated antibody sam-
ples were visualized using confocal microscopy. Z-stack
analyses were used to visualize cross sections of the co-
culture system.
Figure 2. Mono-DCs co-
cultured with either nonsmoker
or smoker NECs have similar
influenza-induced changes in
DC maturation markers.
Twenty-four hours after infection
with influenza, mono-DCs were
harvested from co-cultures and
stained for DC markers, using
flow cytometry. (A) CD451
leukocytes are identified in
the P1 gate. Representative
histogram plots show the ex-
pression of DC markers (B)
CD11b, (C ) CD40, (D)
CD209, (E ) CD11c, and (F )
CD86, and the response to
influenza (fold induction) of
DC markers (G) CD11b, (H )
CD40, (I ) CD209, ( J ) CD11c,
and (K ) CD86. CD11b, CD40,
CD209, and CD11c: nonsmokers,
n 5 6; smokers, n 5 5; CD86:
nonsmokers, n 5 7; smokers,
n 5 6. Data are expressed as
fold induction over nonin-
fected control samples, and
as mean 6 SEM. #P , 0.05
versus noninfected control
samples. MFI, mean fluores-
cence intensity; APC-Cy-7, allo-
phycocyanin cyanine 7; APC,
allophycocyanin; PE, phycoery-
thrin; FITC, fluorescein isothio-
cyanate; PerCP, peridinin
chlorophyll protein.
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smokers (Figure 2J). CD86 was enhanced after infection with
influenza in mono-DCs derived from both nonsmoker and
smoker co-cultureco-cultures (Figure 2K). However, changes
in CD11c and CD86 did not appear to be robust.
NECs and Mono-DCs from Smoker Co-cultures Both Have
Suppressed Antiviral Responses to Infection with Influenza
To determine how antiviral defense responses are modified, NEC/
mono-DC cocultures using NECs from nonsmokers and smokers
were infected from the epithelial side with one multiplicity of
infection of influenza A virus. Total RNA was collected sepa-
rately from both cell types 24 hours after infection and analyzed
for antiviral responses. To determine whether our previous
observations of suppressed influenza-induced IRF-7 expression
in NECs from smokers (13) were also evident in this coculture
model, we analyzed the expression of IRF-7 mRNA (Figure 3A)
and protein (Figure 3B) in NECs from cocultures. Similar to our
previous study (13), the influenza-induced expression of IRF-7
was suppressed in NECs from smokers. In addition to IRF-7, the
influenza-induced expression of PRRs is important in antiviral
defense responses. Figures 3C and 3D show that infection with
influenza did not induce the expression of TLR-3 mRNA in
NECs from smokers (Figure 3C), and that the influenza-induced
expression of RIG-I mRNA was suppressed in NECs from
smokers (Figure 3D). The baseline expression of RIG-I, TLR-3,
and IRF-7 was similar in nonsmoker and smoker NECs, as shown
in Table E1.
To determine whether changes in antiviral defense responses
in NECs from smokers also led to suppressed responses in mono-
DCs, we analyzed the same antiviral defense markers in the
mono-DCs of the co-cultureco-cultures. Infection with influenza
increased the concentrations of IRF-7 (Figure 4A) and RIG-I
(Figure 4B) mRNA in mono-DCs co-cultureco-cultured with
NECs from either nonsmokers or smokers, but this induction was
significantly greater in mono-DCs cultured with NECs from
nonsmokers. Infection with influenza did cause an increase in
the concentrations of TLR-3 mRNA in mono-DCs co-cultured
with NECs from nonsmokers, although this increase did not
reach statistical significance (P 5 0.06) (Figure 4C).
NECs and Mono-DCs from Smoker Co-cultures Exhibit
Suppressed Up-regulation of Th1 Chemokines in Response
to Infection with Influenza
The activation of TLR-3 and RIG-I prompts the production of
inflammatory and immune mediators, including chemokines
such as IP-10 and RANTES (28, 29), which are important for
the migration of immune cells. Therefore, we examined the
expression of these two chemokines in our co-cultures. The
baseline expression of RANTES and IP-10 mRNA is similar in
nonsmoker and smoker NECs from co-cultures (Table E1). The
expression of influenza-induced IP-10 mRNA is suppressed in
both NECs (Figure 5A) and mono-DCs (Figure 5B) from co-
cultures using NECs from smokers. The use of transwell inserts
allowed for separate analyses of protein secretion from the
apical (upper) and basolateral (lower) compartments of the
mono-DC/NEC co-culture system (Figure 1), as reported pre-
viously (27, 30). In both apical washes (Figure 6A) and baso-
lateral supernatants (Figure 6B), the secretion of IP-10 in
influenza-infected co-cultures using smoker NECs was sup-
pressed compared with nonsmoker control samples. Infection
with influenza induces the expression of RANTES in NECs
from both nonsmokers and smokers (Figure 5C), but not in
mono-DCs derived from co-cultures (Figure 5D). Interestingly,
the secretion of RANTES protein is increased in both apical
washes and basolateral supernatants from co-cultures using
influenza-infected NECs from nonsmokers but not from
smokers. Overall, these data indicate that influenza-induced
IP-10 and potentially RANTES are suppressed in both NEC
and mono-DCs co-cultures using NECs from smokers.
Infection with Influenza Increases Th2 Chemokines in NECs
from Smokers
Exposure to cigarette smoke can lead to a Th2 phenotypic
immune response (31). Therefore, after demonstrating that co-
cultures using NECs from smokers show a suppressed expres-
sion of chemokines associated with Th1 responses (e.g., IP-10),
we determined whether chemokines associated with Th2 phe-
notypes were altered. We first analyzed the expression of TSLP,
a Th2 chemokine that is secreted by NECs and is up-regulated
Figure 3. NECs from smokers have suppressed
influenza-induced antiviral responses. NEC total
RNA and whole-cell lysates from nonsmoker and
smoker NEC/mono-DC co-cultures were col-
lected 24 hours after infection with influenza.
(A) Real-time quantitative RT-PCR was per-
formed for interferon regulatory factor–7 (IRF-
7). (B) NEC whole-cell lysates were analyzed by
Western blotting for IRF-7 and then stripped and
probed for b-actin. Real-time quantitative RT-
PCR was performed for (C ) Toll-like receptor–3
(TLR-3) and (D) retinoic acid inducible gene–1
protein (RIG-I). The mRNA expression of targets
was normalized to b-actin, quantified using the
delta delta Ct (DD Ct) method, and expressed as
fold induction over noninfected control samples.
mRNA data are expressed as mean 6 SEM:
nonsmokers, n 5 6; smokers, n 5 6. For Western
blots, representative immunoblots are shown:
nonsmokers, n 5 2; smokers, n 5 2. ##P , 0.01,
###P , 0.001 versus noninfected control sam-
ples. **P , 0.01, ***P , 0.001, nonsmokers
versus smokers.
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in murine lungs after exposure to cigarette smoke extract (32).
Infection with influenza increased the secretion of TSLP into
the basolateral supernatant in co-cultures using NECs from
smokers compared with nonsmokers (Figure 7A). TSLP was not
detectable in the apical compartment (data not shown). TSLP
acts upon DCs to stimulate the production of TARC (19).
Therefore, we determined whether the changes in expression of
TSLP were reflected in an increased expression of TARC in
basolateral supernatants from cocultures using NECs from
smokers. Overall, infection with influenza did not increase
concentrations of TARC in the basolateral supernatants from
NEC/mono-DCs co-cultures using NECs from nonsmokers or
smokers (Figure 7B), and concentrations of TARC were below
detection in the apical compartment (data not shown). Consid-
ering that mono-DCs from healthy individuals contain high
constitutive levels of TARC expression (33), mono-DCs are
likely to contribute heavily to the overall high concentrations of
TARC in the basolateral supernatants. Previous studies showed
that in addition to DCs, TARC can be expressed in other
respiratory cell types, including epithelial cells (34). To de-
termine further if the influenza-induced expression of TARC is
altered in NECs from smokers alone, we designed experiments
in which NECs in the absence of mono-DCs were analyzed.
Figure 7 shows that infection with influenza significantly in-
creased the production of TARC in NECs from smokers, but
not in NECs from nonsmokers, indicating that NECs may be
significant producers of TARC in smokers but not nonsmokers.
DISCUSSION
Communication between DCs and other cell types during an
immune response is crucial for the activation of DCs, and
single-cell culture models using DCs cannot be used to study
this interaction. Our two-cell co-culture model of NECs and
DCs allowed us to determine the interplay between the virally
infected epithelium and DCs, and also to determine how
smoking may interrupt this communication. Using this model,
we demonstrated that in the context of a viral infection, NECs
obtained from smokers demonstrate altered communication
with underlying mono-DCs, creating an overall cytokine micro-
environment that suppresses the interferon-mediated Th1 re-
sponse and enhances the TSLP–TARC–mediated Th2 response.
We showed here that coculturing mono-DCs with NECs
from smokers alters the mono-DC response to infection with
influenza. The nature of this communication is likely through
‘‘wireless’’ cytokine secretion, although other possibilities exist.
Activated DCs were shown to release exovesicles, small membrane-
bound vesicles that can contain cytokine and immune receptors
(35). These exovesicles are capable of activating TNF-a path-
ways in airway epithelial cells in a co-culture model (36). Thus,
in our model, NEC and mono-DCs may have communicated
through exovesicle-mediated pathways. Moreover, a co-culture
model of lung epithelial A549 cells and mono-DCs suggested
that DCs are capable of forming intraepithelial cell projections
through the pores of the cell culture membrane, to engage in
direct epithelial cell–DC contact (24). Although we cannot rule
out such interactions because of the smaller pore size we must
use for efficient cultures of differentiated NECs (0.4-mM versus
the 3.0-mM size used by Blank and colleagues [24]), we doubt
that mono-DC projections play a large role in their activa-
tion. Moreover, the mono-DCs used in our studies did not
exhibit any markers of direct infection with influenza (i.e., no
detectable influenza hemagglutinin RNA; data not shown),
suggesting that they may not have access to the apical surface
where infection is occurring. Therefore, in our model, antiviral
mediator and cytokine expression may have been initiated by
epithelial-derived cytokines and chemokines acting on mono-
DCs. For example, NEC-derived IFNs are secreted by virally
infected epithelial cells (13) and can activate nearby NECs in an
autocrine fashion, to induce the expression of interferon-related
gene products, including TLR-3 (27). Similarly, influenza-
infected NECs could also activate nearby DCs in a paracrine
fashion via IFNa secretion to act upon mono-DC IFNa re-
ceptors, culminating in the transcription of IRF-7, TLR-3, RIG-I,
and IP-10. Thus, the reduced expression of IFNa seen in NECs
from smokers, as shown in our previous study (13), may lead
to suppressed IFN-induced antiviral defense responses in un-
derlying immune cells, such as DCs. Overall, these data
demonstrate that in addition to the release of Type I IFN and
IRF-7 expression (13), the expression of PRRs such as RIG-I and
TLR-3 are suppressed in smoker NECs, potentially result-
ing in the suppressed activation of resident immune cells that
Figure 4. Mono-DCs co-cultured with smoker NECs have suppressed
influenza-induced antiviral responses. RNA isolated from co-cultured
mono-DCs was collected 24 hours after infection with influenza. Real
time quantitative RT-PCR was performed for (A) IRF-7, (B) RIG-I, and (C )
TLR-3. The mRNA expression of targets was normalized to b-actin,
quantified using the DDCt method, and expressed as fold induction
over noninfected control samples. Data are expressed as mean 6 SEM.
Nonsmokers, n 5 5; smokers, n 5 5. #P , 0.05 versus noninfected
control samples. *P , 0.05, nonsmokers versus smokers.
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communicate with the respiratory epithelium during an in-
fluenza infection.
Our data demonstrate that the influenza-induced expression
of IP-10 is reduced in both NECs from smokers and in mono-
DCs co-cultured with NECs from smokers, thereby leading to
overall reductions in the secretion of IP-10 protein in both the
apical and basolateral compartments of co-culture systems.
During an influenza infection, IP-10 is released from NECs to
attract lymphocytes and T cells to the site of infection (37).
Smoke-exposed mice infected with influenza have suppressed
levels of whole-lung IP-10 mRNA, with modified profiles of
CD4/CD8 T cells in their bronchoalveolar lavage fluid and
draining lymph nodes (38). Data from our own laboratory
showed that smokers inoculated with live, attenuated influenza
virus (LAIV) have reduced concentrations of IP-10 in nasal
lavage fluid compared with nonsmoker control samples (T.L.
Noah, personal communication). In addition to T cells, the
suppressed production of IP-10 by the respiratory epithelium
could lead to a suppressed recruitment of other immune cells
such as NK cells. NK cells express the IP-10 receptor CXC
Figure 5. NECs from smokers as well as mono-
DCs derived from co-cultures using smoker
NECs have suppressed influenza-induced Th1
responses. NEC and mono-DC total RNA from
nonsmoker and smoker NEC/mono-DC cocul-
tures was collected 24 hours after infection with
influenza. Real-time quantitative RT-PCR was
performed for interferon gamma–induced pro-
tein 10 (IP-10) in (A) NECs and (B) mono-DCs.
Real-time quantitative RT-PCR was also per-
formed for regulated upon activation, normal
T-cell expressed, and secreted (RANTES) in (C )
NECs and (D) mono-DCs. The mRNA expression
of targets was normalized to b-actin, quantified
using the DDCt method, and expressed as fold
induction over noninfected control samples.
Data are expressed as mean 6 SEM. Non-
smokers, n 5 5; smokers, n 5 5. #P , 0.05,
##P , 0.01, ###P , 0.001 versus noninfected
control samples. *P , 0.05, ***P , 0.001, non-
smokers versus smokers.
Figure 6. NEC/mono-DC co-culture apical
washes and basolateral supernatants using
NECs from smokers have suppressed influ-
enza-induced Th1 chemokines. NEC/mono-
DC co-cultures using NECs from nonsmokers
and smokers were harvested 24 hours after
infection with influenza. IP-10 protein con-
centrations in (A) apical washes (nonsmokers,
n 5 8; smokers, n 5 7) and (B) basolateral su-
pernatants (nonsmokers, n 5 5; smokers, 5 7)
and RANTES protein concentrations in (C )
apical washes (nonsmokers, n 5 8; smokers,
n 5 7) and (D) basolateral supernatants
(nonsmokers, n 5 9; smokers, n 5 7) were
measured by ELISA. #P , 0.05, ##P , 0.01,
###P , 0.001 versus noninfected control
samples. *P , 0.05, ***P , 0.001, non-
smokers versus smokers.
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chemokine receptor 3 and migrate to the respiratory epithelium
during an influenza infection (39). Decreased IP-10 responses
could be responsible for decreased cytotoxic NK cell numbers,
and could explain why levels of granzymes B and K, important
mediators of cytotoxic NK cells, are reduced after influenza
infections of mice exposed to cigarette smoke (38). Thus, the
reduced production of IP-10 by either NECs or DCs after viral
infections could exert a significant impact on the ability to fight
and clear infections. Infection with influenza increases the
secretion of RANTES into the apical and basolateral compart-
ments in nonsmokers but not in smokers, although no difference
was evident between groups. Like IP-10, RANTES is an
important chemokine that is released during infection with
influenza (37) A lack of RANTES response in smokers may
indicate that the NECs of smokers have decreased communi-
cation with immune cells, highlighting the importance of non-
immune cells in orchestrating both innate and adaptive immune
responses to viral infections.
Exposure to cigarette smoke was shown to shift immune
responses from a Th1 to a Th2 phenotype (31). TSLP, a Th2
chemokine, is secreted by epithelial cells and triggers the
expression of TARC in nearby DCs (19). TSLP in epithelial
cells, as well as TARC in DCs, is up-regulated with exposure to
airborne pollutants, including diesel exhaust (40) and cigarette
smoke extract (32). Exposure to cigarette smoke was also shown
to up-regulate the expression of TARC mRNA in whole murine
lungs (41). We showed here that infection with influenza up-
regulates the secretion of TSLP in co-cultures using NECs from
smokers, but not nonsmokers, suggesting that in smokers, the
activation of the TSLP pathway may occur in concert with the
suppression of Th1 chemokines such as IP-10. Smokers’ NECs
also have elevated concentrations of TARC, as shown in the
broncheoalveolar lavage of current and ex-smokers (34). Both
TSLP and TARC were undetectable in apical washes (data not
shown), which also suggests that differentiated NECs may
manifest polarized protein secretion patterns. Our present data
may offer the first example of TSLP and TARC up-regulation
during infection with influenza in the context of smoking, and
suggest that in smokers, Th2 chemokines that alter the viral
immune response from a predominant Th1 phenotype to a Th2
phenotype may originate from both airway epithelial cells and
myeloid cells (e.g., DCs).
In our model, virally infected NECs can communicate with
underlying, immature mono-DCs through cytokine secretion.
Immature DCs develop from monocyte precursors after treat-
ment with GM-CSF and IL-4, and only progress to maturation
through two steps: (1) exposure to a combination of inflamma-
tory cytokines from the respiratory epithelium, and (2) the
acquisition of antigen, with associated increases in costimula-
tory molecules that engage naive T cells (42). Our model of
virally infected NECs did produce inflammatory and immune-
activating cytokines such as Type I IFNs and IL-6 (13), but may
not provide other signals such as TNF-a that are necessary to
induce the production of IL-12 from mature DCs (43). In the
case of an influenza infection, DCs are thought to process
antigen through the phagocytosis of apoptotic cells (42). In our
model, the cell culture membrane that separated NECs from
mono-DCs likely impaired antigen capture by DCs. This may
explain the limited influenza-induced changes in maturation
markers CD11c and CD86 and the lack of influenza-induced
changes in CD40, CD209, and CD11b that we observed during
infection with influenza in both nonsmoker and smoker co-
cultures, despite drastic differences in antiviral responses. In
addition, our model examined the effects of smoking on the
ability of NECs to communicate with mono-DCs from healthy
nonsmoking donors. Peripheral blood mononuclear cells from
smokers demonstrated an overall suppressed Type I IFN re-
sponse to poly-I:C, a mimetic of double-stranded viral RNA
(44). Thus, generating mono-DCs by using monocytes from
smokers in this co-culture model could provide information on
how signals emanating from influenza-infected NECs result in
the different activations and maturation of mono-DCs obtained
from smokers.
NECs comprise a useful model for studying innate immune
responses of the airways. During a respiratory viral infection,
the secretion of antiviral and immune-activating mediators from
the respiratory epithelium engages accessory cells (e.g., NK
cells, DCs, or monocytes) to induce an innate immune response
(45). Mucosal epithelial cells in the nasopharynx act as a first
line of defense, where they must differentiate between harmless
Figure 7. NEC/mono-DC co-culture supernatants using NECs from
smokers have increased influenza-induced concentrations of the Th2
chemokine thymic stromal lymphopoeitin (TSLP). Basolateral supernatants
from NEC/mono-DC co-cultures were collected 24 hours after infection
with influenza, and were analyzed via ELISA for (A) TSLP (nonsmokers, n 5
9; smokers, n 5 8) and (B) TARC (nonsmokers, n 5 10; smokers, n 5 8).
Data are expressed as fold induction over noninfected control samples,
and as mean 6 SEM. #P , 0.05 versus noninfected control samples. *P ,
0.01, nonsmokers versus smokers. (C) Basolateral supernatants from NECs
cultured alone were collected 24 hours after infection with influenza, and
were analyzed for TARC concentrations via ELISA. Data are expressed as
mean 6 SEM. Nonsmokers, n 5 7; smokers, n 5 5. #P , 0.05 versus
noninfected control samples.
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and disease-causing pathogens such as influenza, therefore
setting the stage for a respiratory immune response (45).
Compared with bronchial cells of the lower airways, NECs
have similar profiles of baseline as well as cytokine-stimulated
inflammatory mediators (46). Recent genome-wide expression
analyses showed that gene expression patterns of epithelial cells
from the nose and bronchial region overlap significantly at base-
line, and that similar smoking-induced changes are reflected in
both cell types (47). Previously, we showed that nasal and bron-
chial epithelial cells have comparable influenza-induced IFNa,
IFNb, and IFNV expression, albeit with differing magnitudes of
response (27), further supporting the notion that the smoking-
induced changes we observed in NECs are likely to be present
in the lower airways as well.
As discussed previously (13), NECs from smokers and
nonsmokers, when differentiated in vitro, appear to resemble
their in vivo counterparts, and this resemblance includes the
persistence of high expression of mucin 5B over time (13). As
demonstrated in our previous study, smoking-induced changes
in phenotypes of NECs were associated with epigenetic changes
in these cells. Specifically, we previously showed that suppres-
sion of the influenza-induced expression of IRF-7 in NECs from
smokers was associated with enhanced DNA methylation of the
IRF-7 gene in these cells (13), which also correlates with our
findings here. In addition to IRF-7, DNA methylation patterns
of other genes are likely altered in NECs from smokers, which
may affect influenza-induced defense responses. We are con-
ducting genome-wide analyses of DNA methylation patterns in
NECs from smokers and nonsmokers, to identify other genes
with potential roles during influenza-induced defense responses
whose expression may be modified in NECs from smokers
because of changes in DNA methylation.
The implication that cigarette smoke enhances susceptibility
to infection with influenza extends beyond active smokers, to
affect those nonsmoking individuals exposed to second-hand
smoke (SHS), especially children. Exposure to SHS is estimated
to cause over $10 billion in increased costs of mortality, morbid-
ity, and medical care annually in the United States (48). Exposure
to SHS is a risk factor for respiratory viral infections, including
respiratory syncytial virus, upper and lower respiratory tract
infections, and the common cold (49). Data from our laboratory
showed that individuals exposed to SHS also have suppressed
antiviral responses to LAIV in vivo (T.L. Noah, personal
communication), and to infection with influenza in vitro (un-
published data). Our data here and in previous studies (31)
suggest that chronic exposure to cigarette smoke may decrease
Th1 antiviral responses over time, and increase the likelihood of
developing Th2 responses. Indeed, exposure to cigarette smoke
early in life is a risk factor for the development of allergic
diseases, including atopic asthma (50). Respiratory viral infec-
tions, including influenza, were shown to exacerbate existing
asthma (51). Therefore, exposure to cigarette smoke can exert
a two-pronged deleterious effect on children, first by increasing
the risk of developing asthma, and then by increasing the likeli-
hood that a child will suffer virus-related complications of asthma.
Author Disclosure: L.E.B. received a sponsored grant from the National Institutes
of Health for $10,001–$50,000. J.L.C. received sponsored grants from the Flight
Attendant Medical Research Institute for $50,001–$100,000 and from the
National Institutes of Health for more than $100,001. I.J. received a sponsored
grant from Entegrion for $10,001–$50,000, from the Flight Attendant Medical
Research Institute for $50,001–$100,000, and from the National Institutes of
Health for more than $100,001. K.M.H. does not have a financial relationship
with a commercial entity that has an interest in the subject of this manuscript.
W.Z. does not have a financial relationship with a commercial entity that has an
interest in the subject of this manuscript.
Acknowledgments: The authors thank Sally Ivins and Margret Herbst for their
assistance in developing an institutional review board–approved protocol and for
recruiting subjects into the present study. This manuscript’s content is solely the
responsibility of the authors, and does not necessarily represent the official views
of the National Heart, Lung, and Blood Institute, the National Institutes of Health,
the National Institute of Environmental Health Sciences, or the Howard Hughes
Medical Institute (HHMI). Although the research described in this article was
funded wholly or in part by the United States Environmental Protection Agency
through cooperative agreement CR829522 with the Center for Environmental
Medicine, Asthma, and Lung Biology, it has not been subjected to the agency’s
required peer and policy review, and therefore does not necessarily reflect the
views of the agency, and no official endorsement should be inferred. The
mention of trade names or commercial products does not constitute an
endorsement or recommendation for use.
References
1. Finklea JF, Sandifer SH, Smith DD. Cigarette smoking and epidemic
influenza. Am J Epidemiol 1969;90:390–399.
2. Kark JD, Lebiush M. Smoking and epidemic influenza-like illness in
female military recruits: a brief survey. Am J Public Health 1981;71:
530–532.
3. Kark JD, Lebiush M, Rannon L. Cigarette smoking as a risk factor for
epidemic A(H1N1) influenza in young men. N Engl J Med 1982;307:
1042–1046.
4. Nicholson KG, Kent J, Hammersley V. Influenza A among community-
dwelling elderly persons in Leicestershire during winter 1993–4: ciga-
rette smoking as a risk factor and the efficacy of influenza vaccination.
Epidemiol Infect 1999;123:103–108.
5. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern
Med 2004;164:2206–2216.
6. Bensenor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring
JE, Manson JE. Active and passive smoking and risk of colds in
women. Ann Epidemiol 2001;11:225–231.
7. de Andres AL, Garrido PC, Hernandez-Barrera V, Del Pozo SV, de
Miguel AG, Jimenez-Garcia R. Influenza vaccination among the elderly
Spanish population: trend from 1993 to 2003 and vaccination-related
factors. Eur J Public Health 2007;17:272–277.
8. Johansen H, Nguyen K, Mao L, Marcoux R, Gao RN, Nair C. Influenza
vaccination. Health Rep 2004;15:33–43.
9. MacKenzie JS, MacKenzie IH, Holt PG. The effect of cigarette smoking
on susceptibility to epidemic influenza and on serological responses to
live attenuated and killed subunit influenza vaccines. J Hyg (Lond)
1976;77:409–417.
10. Pyhala R, Takala J, Turunen A, Aho K. Smoking and influenza in the
elderly: a sero-epidemiological study. Eur J Respir Dis 1983;64:212–216.
11. Mancini DA, Mendonca RM, Mendonca RZ, do Prado JA, Andrade
Cde M. Immune response to vaccine against influenza in smokers,
non-smokers, and in individuals holding respiratory complications.
Boll Chim Farm 1998;137:21–25.
12. Robbins CS, Bauer CM, Vujicic N, Gaschler GJ, Lichty BD, Brown EG,
Stampfli MR. Cigarette smoke impacts immune inflammatory responses
to influenza in mice. Am J Respir Crit Care Med 2006;174:1342–1351.
13. Jaspers I, Horvath KM, Zhang W, Brighton LE, Carson JL, Noah TL.
Reduced expression of IRF7 in nasal epithelial cells from smokers
after infection with influenza. Am J Respir Cell Mol Biol 2010;43:
368–375.
14. Sladkova T, Kostolansky F. The role of cytokines in the immune
response to influenza A virus infection. Acta Virol 2006;50:151–162.
15. Bauer CM, Dewitte-Orr SJ, Hornby KR, Zavitz CC, Lichty BD,
Stampfli MR, Mossman KL. Cigarette smoke suppresses Type I
interferon–mediated antiviral immunity in lung fibroblast and epithe-
lial cells. J Interferon Cytokine Res 2008;28:167–179.
16. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon
viral exposure, myeloid and plasmacytoid dendritic cells produce 3
waves of distinct chemokines to recruit immune effectors. Blood 2006;
107:2613–2618.
17. Grayson MH, Holtzman MJ. Emerging role of dendritic cells in re-
spiratory viral infection. J Mol Med 2007;85:1057–1068.
18. Osterlund P, Veckman V, Siren J, Klucher KM, Hiscott J, Matikainen S,
Julkunen I. Gene expression and antiviral activity of alpha/beta
interferons and interleukin-29 in virus-infected human myeloid
dendritic cells. J Virol 2005;79:9608–9617.
19. Lin Y, Wang W, Jin H, Zhong Y, Di J, Zeng S, Saito S. Comparison of
murine thymic stromal lymphopoietin- and polyinosinic polycytidylic
acid–mediated placental dendritic cell activation. J Reprod Immunol
2009;79:119–128.
20. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B,
Gilliet M, Ho S, Antonenko S, Lauerma A, et al. Human epithelial
cells trigger dendritic cell mediated allergic inflammation by pro-
ducing TSLP. Nat Immunol 2002;3:673–680.
244 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL 45 2011
21. Harada M, Hirota T, Jodo AI, Doi S, Kameda M, Fujita K, Miyatake A,
Enomoto T, Noguchi E, Yoshihara S, et al. Functional analysis of the
thymic stromal lymphopoietin variants in human bronchial epithelial
cells. Am J Respir Cell Mol Biol 2009;40:368–374.
22. Rothen-Rutishauser BM, Kiama SG, Gehr P. A three-dimensional
cellular model of the human respiratory tract to study the interaction
with particles. Am J Respir Cell Mol Biol 2005;32:281–289.
23. Rothen-Rutishauser B, Muhlfeld C, Blank F, Musso C, Gehr P. Trans-
location of particles and inflammatory responses after exposure to
fine particles and nanoparticles in an epithelial airway model. Part
Fibre Toxicol 2007;4:9.
24. Blank F, Rothen-Rutishauser B, Gehr P. Dendritic cells and macro-
phages form a transepithelial network against foreign particulate
antigens. Am J Respir Cell Mol Biol 2007;36:669–677.
25. Zhou H, Wang X, Brighton L, Hazucha M, Jaspers I, Carson JL.
Increased nasal epithelial ciliary beat frequency associated with
lifestyle tobacco smoke exposure. Inhal Toxicol 2009;21:875–881.
26. Jaspers I, Ciencewicki JM, Zhang W, Brighton LE, Carson JL, Beck
MA, Madden MC. Diesel exhaust enhances influenza virus infections
in respiratory epithelial cells. Toxicol Sci 2005;85:990–1002.
27. Ciencewicki JM, Brighton LE, Jaspers I. Localization of Type I in-
terferon receptor limits interferon-induced TLR3 in epithelial cells.
J Interferon Cytokine Res 2009;29:289–297.
28. Taima K, Imaizumi T, Yamashita K, Ishikawa A, Fujita T, Yoshida H,
Takanashi S, Okumura K, Satoh K. Expression of IP-10/CXCL10 is
upregulated by double-stranded RNA in BEAS-2B bronchial epithe-
lial cells. Respiration. 2006;73:360–364.
29. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-
Tahar M. Involvement of Toll-like receptor 3 in the immune response
of lung epithelial cells to double-stranded RNA and influenza A virus.
J Biol Chem 2005;280:5571–5580.
30. Jaspers I, Flescher E, Chen LC. Respiratory epithelial cells display
polarity in their release of the chemokine IL-8 after exposure to
ozone. Inflamm Res 1997;46:S173–S174.
31. Robays LJ, Maes T, Joos GF, Vermaelen KY. Between a cough and
a wheeze: dendritic cells at the nexus of tobacco smoke–induced
allergic airway sensitization. Mucosal Immunol 2009;2:206–219.
32. Nakamura Y, Miyata M, Ohba T, Ando T, Hatsushika K, Suenaga F,
Shimokawa N, Ohnuma Y, Katoh R, Ogawa H, et al. Cigarette smoke
extract induces thymic stromal lymphopoietin expression, leading to
T(H)2-type immune responses and airway inflammation. J Allergy
Clin Immunol 2008;122:1208–1214.
33. Vissers JL, Hartgers FC, Lindhout E, Teunissen MB, Figdor CG, Adema
GJ. Quantitative analysis of chemokine expression by dendritic cell
subsets in vitro and in vivo. J Leukoc Biol 2001;69:785–793.
34. Ying S, O’Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, Robinson
D, Zhang G, Zhao J, Lee TH, et al. Thymic stromal lymphopoietin
expression is increased in asthmatic airways and correlates with
expression of Th2-attracting chemokines and disease severity.
J Immunol 2005;174:8183–8190.
35. Obregon C, Rothen-Rutishauser B, Gitahi SK, Gehr P, Nicod LP.
Exovesicles from human activated dendritic cells fuse with resting
dendritic cells, allowing them to present alloantigens. Am J Pathol
2006;169:2127–2136.
36. Obregon C, Rothen-Rutishauser B, Gerber P, Gehr P, Nicod LP. Active
uptake of dendritic cell–derived exovesicles by epithelial cells induces
the release of inflammatory mediators through a TNF-alpha–mediated
pathway. Am J Pathol 2009;175:696–705.
37. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S.
Molecular pathogenesis of influenza A virus infection and virus-
induced regulation of cytokine gene expression. Cytokine Growth
Factor Rev 2001;12:171–180.
38. Gualano RC, Hansen MJ, Vlahos R, Jones JE, Park-Jones RA,
Deliyannis G, Turner SJ, Duca KA, Anderson GP. Cigarette smoke
worsens lung inflammation and impairs resolution of influenza in-
fection in mice. Respir Res 2008;9:53.
39. Toapanta FR, Ross TM. Impaired immune responses in the lungs of
aged mice following influenza infection. Respir Res 2009;10:112.
40. Bleck B, Tse DB, Curotto de Lafaille MA, Zhang F, Reibman J. Diesel
exhaust particle–exposed human bronchial epithelial cells induce
dendritic cell maturation and polarization via thymic stromal lym-
phopoietin. J Clin Immunol 2008;28:147–156.
41. Ritter M, Goggel R, Chaudhary N, Wiedenmann A, Jung B, Weith A,
Seither P. Elevated expression of TARC (CCL17) and MDC
(CCL22) in models of cigarette smoke–induced pulmonary inflam-
mation. Biochem Biophys Res Commun 2005;334:254–262.
42. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ,
Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev
Immunol 2000;18:767–811.
43. Kim HJ, Kim HO, Lee K, Baek EJ, Kim HS. Two-step maturation of
immature DCs with proinflammatory cytokine cocktail and poly(I:C)
enhances migratory and T cell stimulatory capacity. Vaccine 2010;28:
2877–2886.
44. Mian MF, Stampfli MR, Mossman KL, Ashkar AA. Cigarette smoke
attenuation of poly I:C–induced innate antiviral responses in human
PBMC is mainly due to inhibition of IFN-beta production. Mol
Immunol 2009;46:821–829.
45. Reynolds HY. Modulating airway defenses against microbes. Curr Opin
Pulm Med 2002;8:154–165.
46. McDougall CM, Blaylock MG, Douglas JG, Brooker RJ, Helms PJ,
Walsh GM. Nasal epithelial cells as surrogates for bronchial epithelial
cells in airway inflammation studies. Am J Respir Cell Mol Biol 2008;
39:560–568.
47. Sridhar S, Schembri F, Zeskind J, Shah V, Gustafson AM, Steiling K,
Liu G, Dumas YM, Zhang X, Brody JS, et al. Smoking-induced gene
expression changes in the bronchial airway are reflected in nasal and
buccal epithelium. BMC Genomics 2008;9:259.
48. Behan DF, Eriksen MP, Lin Y. Economic effects of environmental
tobacco smoke. Schaumburg, IL: Society of Actuaries; 2005.
49. Ciencewicki J, Jaspers I. Air pollution and respiratory viral infection.
Inhal Toxicol 2007;19:1135–1146.
50. Metsios GS, Flouris AD, Koutedakis Y. Passive smoking, asthma and
allergy in children. Inflamm Allergy Drug Targets 2009;8:348–352.
51. Hansbro NG, Horvat JC, Wark PA, Hansbro PM. Understanding the
mechanisms of viral induced asthma: new therapeutic directions.
Pharmacol Ther 2008;117:313–353.
Horvath, Brighton, Zhang, et al.: Smokers’ Epithelial Cell Responses to Influenza 245
